Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP680235.RAzllg1U_TiCebxSY5X8hLfb3Wum7uRe_Hhij6rfxPAw8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP680235.RAzllg1U_TiCebxSY5X8hLfb3Wum7uRe_Hhij6rfxPAw8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP680235.RAzllg1U_TiCebxSY5X8hLfb3Wum7uRe_Hhij6rfxPAw8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP680235.RAzllg1U_TiCebxSY5X8hLfb3Wum7uRe_Hhij6rfxPAw8130_provenance.
- NP680235.RAzllg1U_TiCebxSY5X8hLfb3Wum7uRe_Hhij6rfxPAw8130_assertion description "[Furthermore, patients affected by essential thrombocythemia who are carriers of the Janus kinase 2 Val617Phe mutation show a higher incidence of venous thromboembolism both before, and at the time of diagnosis, compared with noncarriers, and recent evidence of splanchnic and cerebral vein thrombosis in carriers of the Janus kinase 2 Val617Phe mutation has been reported.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP680235.RAzllg1U_TiCebxSY5X8hLfb3Wum7uRe_Hhij6rfxPAw8130_provenance.
- NP680235.RAzllg1U_TiCebxSY5X8hLfb3Wum7uRe_Hhij6rfxPAw8130_assertion evidence source_evidence_literature NP680235.RAzllg1U_TiCebxSY5X8hLfb3Wum7uRe_Hhij6rfxPAw8130_provenance.
- NP680235.RAzllg1U_TiCebxSY5X8hLfb3Wum7uRe_Hhij6rfxPAw8130_assertion SIO_000772 18600099 NP680235.RAzllg1U_TiCebxSY5X8hLfb3Wum7uRe_Hhij6rfxPAw8130_provenance.
- NP680235.RAzllg1U_TiCebxSY5X8hLfb3Wum7uRe_Hhij6rfxPAw8130_assertion wasDerivedFrom befree-2016 NP680235.RAzllg1U_TiCebxSY5X8hLfb3Wum7uRe_Hhij6rfxPAw8130_provenance.
- NP680235.RAzllg1U_TiCebxSY5X8hLfb3Wum7uRe_Hhij6rfxPAw8130_assertion wasGeneratedBy ECO_0000203 NP680235.RAzllg1U_TiCebxSY5X8hLfb3Wum7uRe_Hhij6rfxPAw8130_provenance.
- befree-2016 importedOn "2016-02-19" NP680235.RAzllg1U_TiCebxSY5X8hLfb3Wum7uRe_Hhij6rfxPAw8130_provenance.